NCT06537752View on ClinicalTrials.gov

A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

1,052

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Breast Cancer
Trial Locations (2)

11759

NOT_YET_RECRUITING

Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si

06973

RECRUITING

Chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT06537752 - A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients | Biotech Hunter | Biotech Hunter